You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
16 November 2020
MS Pharma is set to launch Enzymatica’s common cold spray, ColdZyme, under its registered trademarks in the Middle East and North Africa (MENA).
13 November 2020
HRA Pharma has appointed OTC Medical as exclusive distributor for its ellaOne, NorLevo and Compeed brands in the Netherlands with effect from January 2021.
13 November 2020
Zur Rose Group is joining forces with health insurers to create a digital healthcare platform in Switzerland, and McKesson has released financial results.
11 November 2020
The European Union and the UK have reached an agreement on medicines regulation in Northern Ireland, while the Proprietary Association of Great Britain (PAGB) is calling on the National Health service (NHS) to harness online resources to boost self care.
9 November 2020
Six "skinterviews" demonstrate the “life-changing power of dermatological skincare” in Beiersdorf’s first-ever global umbrella brand campaign for Eucerin.
9 November 2020
Bayer Consumer Health’s portfolio of vitamins, minerals and supplements (VMS) continued to record strong sales growth in the third quarter of 2020, but sales of the company’s Allergy & Cold products continued to decline.
9 November 2020
CVS Health will have a new chief executive officer from 1 February 2021.
6 November 2020
Pierre Fabre has divested two skincare brands, Orkla is selling its skincare business in Poland, and private-equity firm EQT has invested in BioGaia.
6 November 2020
The COVID-19 pandemic has led to a “meaningful and accelerated” purchasing shift from branded to store-brand products, according to Murray Kessler, Perrigo’s president and chief executive officer, as well as a channel shift from brick-and-mortar to e-commerce.
5 November 2020
France’s Boiron expects new products to lift its fortunes in the fourth quarter of 2020 as sales in its home market of France dropped by 18.1% in the third quarter following changes to the reimbursement of homeopathic medicines.